https://stock.noler.com/us/stock/pharmasset-inc https://stock.noler.com/us/stock/pharmasset-inc/accounts-payable https://stock.noler.com/us/stock/pharmasset-inc/accrued-liabilities-current https://stock.noler.com/us/stock/pharmasset-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/pharmasset-inc/accumulated-depreciation https://stock.noler.com/us/stock/pharmasset-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/pharmasset-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/pharmasset-inc/additional-paid-in-capital https://stock.noler.com/us/stock/pharmasset-inc/adjustment-for-amortization https://stock.noler.com/us/stock/pharmasset-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/pharmasset-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/pharmasset-inc/basic-shares https://stock.noler.com/us/stock/pharmasset-inc/capital-expenditures https://stock.noler.com/us/stock/pharmasset-inc/cash-and-equivalents https://stock.noler.com/us/stock/pharmasset-inc/cash-flow-breakdown https://stock.noler.com/us/stock/pharmasset-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/pharmasset-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/pharmasset-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/pharmasset-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/pharmasset-inc/common-stock-value https://stock.noler.com/us/stock/pharmasset-inc/comprehensive-income https://stock.noler.com/us/stock/pharmasset-inc/costs-and-expenses https://stock.noler.com/us/stock/pharmasset-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/pharmasset-inc/current-assets https://stock.noler.com/us/stock/pharmasset-inc/current-liabilities https://stock.noler.com/us/stock/pharmasset-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/pharmasset-inc/debt-issued https://stock.noler.com/us/stock/pharmasset-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/pharmasset-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/pharmasset-inc/debt-repaid https://stock.noler.com/us/stock/pharmasset-inc/debt-unamortized-discount https://stock.noler.com/us/stock/pharmasset-inc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/pharmasset-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/pharmasset-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/pharmasset-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/pharmasset-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/pharmasset-inc/deferred-revenue https://stock.noler.com/us/stock/pharmasset-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/pharmasset-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/pharmasset-inc/depreciation https://stock.noler.com/us/stock/pharmasset-inc/depreciation-and-amortization https://stock.noler.com/us/stock/pharmasset-inc/diluted-shares https://stock.noler.com/us/stock/pharmasset-inc/due-from-related-parties-current https://stock.noler.com/us/stock/pharmasset-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/pharmasset-inc/effective-tax-rate https://stock.noler.com/us/stock/pharmasset-inc/financing-cash-flow https://stock.noler.com/us/stock/pharmasset-inc/general-and-administrative-expense https://stock.noler.com/us/stock/pharmasset-inc/income-tax https://stock.noler.com/us/stock/pharmasset-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/pharmasset-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/pharmasset-inc/increase-decrease-in-deferred-rent-receivables https://stock.noler.com/us/stock/pharmasset-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/pharmasset-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/pharmasset-inc/insider-transactions-preferred https://stock.noler.com/us/stock/pharmasset-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/pharmasset-inc/insider-transactions-warrants https://stock.noler.com/us/stock/pharmasset-inc/interest-expense https://stock.noler.com/us/stock/pharmasset-inc/interest-paid https://stock.noler.com/us/stock/pharmasset-inc/investing-cash-flow https://stock.noler.com/us/stock/pharmasset-inc/investment-income-net https://stock.noler.com/us/stock/pharmasset-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/pharmasset-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/pharmasset-inc/long-term-debt https://stock.noler.com/us/stock/pharmasset-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/pharmasset-inc/maturities-of-shortterm-investments https://stock.noler.com/us/stock/pharmasset-inc/net-change-in-cash https://stock.noler.com/us/stock/pharmasset-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/pharmasset-inc/operating-cash-flow https://stock.noler.com/us/stock/pharmasset-inc/operating-income https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/pharmasset-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/pharmasset-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/pharmasset-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/pharmasset-inc/other-noncurrent-assets https://stock.noler.com/us/stock/pharmasset-inc/other-nonoperating-income https://stock.noler.com/us/stock/pharmasset-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/pharmasset-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/pharmasset-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/pharmasset-inc/pension-and-other-postretirement-benefit-expense https://stock.noler.com/us/stock/pharmasset-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/pharmasset-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/pharmasset-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/pharmasset-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/pharmasset-inc/profit-loss https://stock.noler.com/us/stock/pharmasset-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/pharmasset-inc/property-plant-equipment https://stock.noler.com/us/stock/pharmasset-inc/public-float https://stock.noler.com/us/stock/pharmasset-inc/recognition-of-deferred-revenue https://stock.noler.com/us/stock/pharmasset-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/pharmasset-inc/research-and-development https://stock.noler.com/us/stock/pharmasset-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/pharmasset-inc/retained-earnings https://stock.noler.com/us/stock/pharmasset-inc/revenue https://stock.noler.com/us/stock/pharmasset-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/pharmasset-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-10-k https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-10-q https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-15-12b https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-25-nse https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-8-k https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-certnas https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-ct-order https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-def-14a https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-defr14a https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-regdex https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/pharmasset-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/pharmasset-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/pharmasset-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/pharmasset-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/pharmasset-inc/shareholders-equity https://stock.noler.com/us/stock/pharmasset-inc/shares-authorized https://stock.noler.com/us/stock/pharmasset-inc/shares-issued https://stock.noler.com/us/stock/pharmasset-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/pharmasset-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/pharmasset-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/pharmasset-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/pharmasset-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/pharmasset-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/pharmasset-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/pharmasset-inc/stock-based-compensation https://stock.noler.com/us/stock/pharmasset-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/pharmasset-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/pharmasset-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/pharmasset-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/pharmasset-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/pharmasset-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/pharmasset-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/pharmasset-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/pharmasset-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/pharmasset-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/pharmasset-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/pharmasset-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-exercisable-remaining-term https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/pharmasset-inc/stock-options-vested-and-expected-to-vest-outstanding-remaining-term https://stock.noler.com/us/stock/pharmasset-inc/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/pharmasset-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/pharmasset-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/pharmasset-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/pharmasset-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/pharmasset-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/pharmasset-inc/total-assets https://stock.noler.com/us/stock/pharmasset-inc/total-liabilities https://stock.noler.com/us/stock/pharmasset-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/pharmasset-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/pharmasset-inc/warrants-and-rights-outstanding